ClassID:

101313

C08L5/10 - CPC Classification

Classification description:

Compositions of polysaccharides or of their derivatives not provided for in groups or Heparin; Derivatives thereof

Recent Application in this class:
#1
20250134916
2025-05-01

Compositions and Methods for Reducing Oxidative Damage

#2
20250066562
2025-02-27

METHOD AND MATERIAL FOR DIFFERENTIATED SEQUESTRATION OF SUBSTANCES OF DIFFERENT SUBSTANCE GROUPS WITH THE AID OF HYDROGELS CONTAINING SULPHATED OR SULPHONATED COMPONENTS

#3
20250066561
2025-02-27

METHOD AND MATERIAL FOR DIFFERENTIATED SEQUESTRATION OF SUBSTANCES OF DIFFERENT SUBSTANCE GROUPS WITH THE AID OF HYDROGELS CONTAINING SULPHATED OR SULPHONATED COMPONENTS

#4
20250025601
2025-01-23

PNEUMATOSPUN BIOPOLYMER SCAFFOLDS AND METHODS FOR THEIR PRODUCTION

#5
20240360290
2024-10-31

Dendritic Macroporous Hydrogels Prepared By Crystal Templating

#6
20240307593
2024-09-19

ENGINEERED HEPARIN BIOACTIVE MATRIX FOR CLINICAL APPLICATION OF BLOOD CONTACTING SURFACE AND METHOD OF MANUFACTURING THE SAME

#7
20240301092
2024-09-12

HEPARIN FROM MODIFIED MST CELLS AND METHODS OF MAKING AND USING

#8
20240262989
2024-08-08

CONFIGURABLE HYDROGEL MATERIAL AND METHOD FOR CONFIGURING HYDROGEL MATERIALS FOR SEQUESTERING AND/OR RELEASING BIOACTIVE SUBSTANCES

#9
20240117158
2024-04-11

COMPOSITIONS AND METHODS FOR TREATING A DISORDER OR DEFECT IN SOFT TISSUE

#10
20240100221
2024-03-28

PREPARATION AND/OR FORMULATION OF PROTEINS CROSS-LINKED WITH POLYSACCHARIDES

#11
20240041907
2024-02-08

Compositions and methods for reducing oxidative damage

#12
20230383086
2023-11-30

Dendritic macroporous hydrogels prepared by crystal templating

#13
20230324366
2023-10-12

RAPID TESTING MECHANISM AND METHOD FOR RESPIRATORY VIRAL PATHOGENS

#14
20230151400
2023-05-18

BIOSYNTHETIC HEPARIN

#15
20230136938
2023-05-04

AGENT TO BE USED IN INTRAOCULAR MEMBRANE DETACHMENT SURGERY

#16
20230111578
2023-04-13

RAPID TESTING MECHANISM AND METHOD FOR RESPIRATORY VIRAL PATHOGENS

#17
20220348745
2022-11-03

Compositions and Methods for Treating a Disorder or Defect in Soft Tissue

#18
20220110959
2022-04-14

Compositions and methods for reducing oxidative damage

#19
20220008612
2022-01-13

PREPARATION AND/OR FORMULATION OF PROTEINS CROSS-LINKED WITH POLYSACCHARIDES

#20
20210379253
2021-12-09

Immobilised biological entities

#21
20210238379
2021-08-05

Dendritic macroporous hydrogels prepared by crystal templating

#22
20210154373
2021-05-27

METHOD FOR IMMOBILIZING HEPARIN AND NO-GENERATING CATALYST AND CARDIOVASCULAR DEVICE HAVING SURFACE MODIFIED USING THE SAME

#23
20210100935
2021-04-08

ENGINEERED HEPARIN BIOACTIVE MATRIX FOR CLINICAL APPLICATION OF BLOOD CONTACTING SURFACE AND METHOD OF MANUFACTURING THE SAME

#24
20210008249
2021-01-14

Porous biomaterials for tissue regeneration

#25
20200246504
2020-08-06

Preparation and/or formulation of proteins cross-linked with polysaccharides

#26
20200062919
2020-02-27

Dendritic macroporous hydrogels prepared by crystal templating

#27
20200040147
2020-02-06

METHOD AND MATERIAL FOR DIFFERENTIATED SEQUESTRATION OF SUBSTANCES OF DIFFERENT SUBSTANCE GROUPS WITH THE AID OF HYDROGELS CONTAINING SULPHATED OR SULPHONATED COMPONENTS

#28
20190350956
2019-11-21

Compositions and Methods for Reducing Oxidative Damage

#29
20190225998
2019-07-25

Biosynthetic heparin

#30
20190136018
2019-05-09

Compositions and Methods for Treating a Disorder or Defect in Soft Tissue

#31
20190030494
2019-01-31

Cryogel for the removal of heparins and heparinoids from aqueous solutions, physiological solutions and biological fluids, preparation process and uses thereof

#32
20180355127
2018-12-13

Light-activated preparation of hydrogels

#33
20180318334
2018-11-08

DRUG CONTAINING CATIONIZED CHITOSAN

#34
20180228834
2018-08-16

PREVENTION AND/OR TREATMENT OF CANCER AND/OR CANCER METASTASIS

#35
20180163012
2018-06-14

Dendritic macroporous hydrogels prepared by crystal templating

#36
20180153917
2018-06-07

Compositions and methods for reducing oxidative damage

#37
20180100048
2018-04-12

METHOD FOR MANUFACTURING WATER-INSOLUBLE MOLDED ARTICLE AND WATER-INSOLUBLE MOLDED ARTICLE

#38
20170360677
2017-12-21

Cosmetic process for attenuating wrinkles

#39
20170333477
2017-11-23

NOVEL FORMULATION OF PHYSIOLOGICAL CHITOSAN-INORGANIC SALT SOLUTION/BLOOD MIXTURES FOR TISSUE REPAIR

#40
20170203001
2017-07-20

Preparation and/or formulation of proteins cross-linked with polysaccharides

#41
20170096549
2017-04-06

MULTIVALENT CATION FORMULATIONS OF PARTIALLY DESULFATED HEPARINS

#42
20160208064
2016-07-21

Method for manufacturing water-insoluble molded article and water-insoluble molded article

#43
20160122446
2016-05-05

Reversible heparin molecules and methods of making and using the same

#44
20150290230
2015-10-15

Compositions and methods for reducing oxidative damage

#45
20140349933
2014-11-27

Self-assembled composite ultrasmall peptide-polymer hydrogels

#46
20140242126
2014-08-28

Dendritic macroporous hydrogels prepared by crystal templating

#47
20140114056
2014-04-24

Evaluating heparin preparations

#48
20140094544
2014-04-03

Plasticizer, a biodegradable material comprising the plasticizer and application thereof

#49
20140013998
2014-01-16

Enzymatically degradable compositions

#50
20130296528
2013-11-07

Preparation and/or formulation of proteins cross-linked with polysaccharides

#51
20130288932
2013-10-31

METHODS OF CRYODESICCATING A BROTH COMPRISING A BIOPOLYMER OF AN EXOPOLYSACCHARIDE

#52
20130287836
2013-10-31

High strength chitin composite material and method of making

#53
20130052155
2013-02-28

Compositions and Methods for Treating a Disorder or Defect in Soft Tissue

#54
20130029934
2013-01-31

Silyl-derivatives of polysaccharides

#55
20130023509
2013-01-24

Hyaluronic acid based copolymers

#56
20130023508
2013-01-24

Hyaluronic acid based copolymers

#57
20130023507
2013-01-24

Hyaluronic acid based copolymers

#58
20120321721
2012-12-20

NOVEL FORMULATION OF PHYSIOLOGICAL CHITOSAN-INORGANIC SALT SOLUTION/BLOOD MIXTURES FOR TISSUE REPAIR

#59
20120315300
2012-12-13

Insertable medical devices with a porous bed for delivering nano-carriers to a target site and methods of preparing the same

#60
20120207791
2012-08-16

Immobilized biologically active entities having a high degree of biological activity

#61
20120189699
2012-07-26

Polysaccharide gel formulation having multi-stage bioactive agent delivery

#62
20120094310
2012-04-19

Method for determining biologically active HGF

#63
20120088852
2012-04-12

Plasticizer, a biodegradable material comprising the plasticizer and application thereof

#64
20120058943
2012-03-08

Bioactive hydrogel

#65
20110293689
2011-12-01

Immobilized biologically active entities having a high degree of biological activity

#66
20110274733
2011-11-10

Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same

#67
20110268690
2011-11-03

Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same

#68
20110256186
2011-10-20

Biomaterial based on Wharton's jelly from the human umbilical cord

#69
20110251281
2011-10-13

Composite Material Comprising High-Molecular-Weight Matrix and Low-Molecular-Weight Organic Compound and Process For Producing Same

#70
20110165218
2011-07-07

Therapeutic bone growth and regeneration

#71
20110070440
2011-03-24

Artificial Organelle On A Digital Microfluidic Chip Used To Redesign The Biological Activities of Heparan Sulfate

#72
20110048946
2011-03-03

Method for finger-printing heparins

#73
20110009955
2011-01-13

Compounds and method for coating surfaces in a hemocompatible manner

#74
20110008442
2011-01-13

Dendritic macroporous hydrogels prepared by crystal templating

#75
20100317617
2010-12-16

Silver nanoparticles as anti-microbial

#76
20100298769
2010-11-25

IMPLANTABLE MEDICAL DEVICES FOR THERAPEUTIC AGENT DELIVERY

#77
20100298260
2010-11-25

Non-anticoagulant polysaccharide compositions

#78
20100136070
2010-06-03

METHODS, DEVICES, AND COMPOSITIONS FOR DERMAL FILLING

#79
20100098764
2010-04-22

Polysaccharide gel formulation having multi-stage bioactive agent delivery

#80
20100023101
2010-01-28

BIOCOMPATIBLE COMPOSITES

#81
20090202607
2009-08-13

Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions

#82
20090197832
2009-08-06

Polymer mixtures of anionic and cationic polysaccharides and use thereof

#83
20090149570
2009-06-11

Plasticizer, a biodegradable material comprising the plasticizer and application thereof

#84
20090149424
2009-06-11

Heparin conjugates and methods

#85
20090098174
2009-04-16

Heparin coating of biological tissue

#86
20080299171
2008-12-04

Growth factor modified extracellular matrix material preparation and methods for preparation and use thereof

#87
20080274156
2008-11-06

Composition forstimulating bone growth and differentiation and method for isolating same

#88
20080269875
2008-10-30

Coating for a medical device having an anti-thrombotic conjugate

#89
20080171722
2008-07-17

Orthogonally protected disaccharide building blocks for synthesis of heparin

#90
20080091234
2008-04-17

Method for modifying a medical implant surface for promoting tissue growth

#91
20080089919
2008-04-17

Immobilized biologically active entities having a high degree of biological activity

#92
20080014239
2008-01-17

Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions

#93
20070213258
2007-09-13

Endotoxin adsorbent, and method for removing endotoxin using the same

#94
20070212393
2007-09-13

COMPOSITIONS AND COATINGS FOR IMPLANTABLE MEDICAL DEVICES

#95
20070212388
2007-09-13

COMPOSITIONS COMPRISING POROUS ARTICLES AND USES IN IMPLANTABLE MEDICAL DEVICES

#96
20070212387
2007-09-13

COATINGS FOR IMPLANTABLE MEDICAL DEVICES

#97
20070212386
2007-09-13

COATINGS FOR IMPLANTABLE MEDICAL DEVICES

#98
20070123489
2007-05-31

Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome

#99
20070117779
2007-05-24

Use of lipid conjugates in the treatment of disease

#100
20070116768
2007-05-24

Sustained release preparations composed of biocompatible complex microparticles

#101
20060293275
2006-12-28

Hgf production accelerator containing heparin-like oligosaccharide

#102
20060292030
2006-12-28

Process for the preparation of sterile polysaccharide solutions

#103
20060154894
2006-07-13

Biologically active surfaces and methods of their use

#104
20060147412
2006-07-06

Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same

#105
20060079483
2006-04-13

Orthogonally protected disaccharide building blocks for synthesis of heparin oligosaccharides

#106
20060073183
2006-04-06

Therapeutic composition and a method of coating implantable medical devices

#107
20060057098
2006-03-16

Photoreactive polysaccharide, photocrosslinked polysaccharide product and method of making same and medical materials made from the crosslinked polysaccharide

#108
20050244363
2005-11-03

Hyaluronic acid based copolymers

#109
20050176678
2005-08-11

Compounds and method for coating surfaces in a haemocompatibe manner